Invacare Corp. (NYSE:IVC) declined substantially following its Q2 2014 earnings report despite the fact that revenue actually came in higher than analyst expectations. We believe Mr. Market is being incredibly short-sighted on IVC and we believe the stock offers a tremendous risk/reward opportunity for those investors with longer time horizons. The company is the global leader in mobility and seating products, but it has been dramatically under-earning for the past two years due to an FDA consent decree that has temporarily shut down production of its high-margin custom power wheelchair business. IVC has maintained the production infrastructure during this period, which has dramatically impaired the profitability of the consolidated business. Furthermore, IVC has been overspending on consultants and...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|